α-Hispanolol Induces Apoptosis and Suppresses Migration and Invasion of Glioblastoma Cells Likely via Downregulation of MMP-2/9 Expression and p38MAPK Attenuation by Sanchez-Martin, Vanesa et al.
1 September 2019 | Volume 10 | Article 935
ORIGINAL RESEARCH
doi: 10.3389/fphar.2019.00935
published: 03 September 2019
Frontiers in Pharmacology | www.frontiersin.org
α-Hispanolol Induces Apoptosis 
and Suppresses Migration and 
Invasion of Glioblastoma Cells 
Likely via Downregulation of MMP-
2/9 Expression and p38MAPK 
Attenuation
Vanesa Sánchez-Martín 1,2, Lidia Jiménez-García 1†, Sandra Herranz 1, Alfonso Luque 1, 
Paloma Acebo 1, Ángel Amesty 3, Ana Estévez-Braun 3, Beatriz de las Heras 2* and 
Sonsoles Hortelano 1*
1 Unidad de Terapias Farmacológicas, Área de Genética Humana, Instituto de Investigación de Enfermedades Raras (IIER), 
Instituto de Salud Carlos III, Madrid, Spain, 2 Departamento de Farmacología, Farmacognosia y Botánica, Facultad de 
Farmacia, Universidad Complutense de Madrid (UCM), Madrid, Spain, 3 Departamento de Química Orgánica, Instituto 
Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, La Laguna, Tenerife, Spain
α-Hispanolol (α-H) is a labdane diterpenoid that has been shown to induce apoptosis 
in several human cancer cells. However, the effect of α-H in human glioblastoma cells 
has not been described. In the present work, we have investigated the effects of 
α-H on apoptosis, migration, and invasion of human glioblastoma cells with the aim 
of identifying the molecular targets underlying its mechanism of action. The results 
revealed that α-H showed significant cytotoxicity against human glioma cancer cell 
lines U87 and U373 in a concentration- and time-dependent manner. This effect was 
higher in U87 cells and linked to apoptosis, as revealed the increased percentage 
of sub-G1 population by cell cycle analysis and acquisition of typical features of 
apoptotic cell morphology. Apoptosis was also confirmed by significant presence of 
annexin V-positive cells and caspase activation. Pretreatment with caspase inhibitors 
diminishes the activities of caspase 8, 9, and 3 and maintains the percentage of 
viable glioblastoma cells, indicating that α-H induced cell apoptosis through both the 
extrinsic and the intrinsic pathways. Moreover, we also found that α-H downregulated 
the anti-apoptotic Bcl-2 and Bcl-xL proteins and activated the pro-apoptotic Bid and 
Bax proteins. On the other hand, α-H exhibited inhibitory effects on the migration and 
invasion of U87 cells in a concentration-dependent manner. Furthermore, additional 
experiments showed that α-H treatment reduced the enzymatic activities and protein 
levels of matrix metalloproteinase MMP-2 and MMP-9 and increased the expression of 
TIMP-1 inhibitor, probably via p38MAPK regulation. Finally, xenograft assays confirmed 
the anti-glioma efficacy of α-H. Taken together, these findings suggest that α-H may 
exert anti-tumoral effects in vitro and in vivo through the inhibition of cell proliferation 
Edited by: 
Muriel Cuendet, 
Université de Genève, Switzerland
Reviewed by: 
Takahiro Kodama, 
Osaka University, Japan 
William Chi-Shing Tai, 
Hong Kong Polytechnic University, 
Hong Kong
*Correspondence: 






Molecular Neurobiology Laboratory, 
Salk Institute for Biological Studies, 
La Jolla, CA, United States,
Specialty section: 
This article was submitted to 
Ethnopharmacology, 
a section of the journal 
Frontiers in Pharmacology
Received: 22 February 2019
Accepted: 22 July 2019
Published: 03 September 2019
Citation: 
Sánchez-Martín V, Jiménez-García L, 
Herranz S, Luque A, Acebo P, 
Amesty Á, Estévez-Braun A, 
de las Heras B and Hortelano S 
(2019) α-Hispanolol Induces 
Apoptosis and Suppresses Migration 
and Invasion of Glioblastoma 
Cells Likely via Downregulation 
of MMP-2/9 Expression 
and p38MAPK Attenuation. 
Front. Pharmacol. 10:935. 
doi: 10.3389/fphar.2019.00935
Anti-Tumoral Effects of α-Hispanolol in GlioblastomaSánchez-Martín et al.
2 September 2019 | Volume 10 | Article 935Frontiers in Pharmacology | www.frontiersin.org
INTRODUCTION
Glioblastoma multiforme (GBM) is a rare disease with an 
incidence of 2–3 per 100,000 people. It is considered as one 
of the most malignant primary brain tumors in adults being 
associated with a bad prognosis. Despite standard treatments 
(surgery, radiotherapy, and chemotherapy), patient survival 
remains poor, as reflected by a median overall survival of less 
than 15 months (Stupp et al., 2005; Stupp et al., 2009). Resistance 
to apoptotic cell death, supported angiogenesis, and glioma cell 
invasion are believed to be the main mechanisms by which GBM 
shows resistance against conventional chemotherapy (Onishi 
et al., 2011). Nevertheless, the exact procedures driving GBM 
pathogenesis are not well known. Therefore, further research is 
required to understand the underlying mechanisms of tumor 
progression in order to design more effective therapies.
Natural products are one of the major sources of novel 
compounds for the treatment of many human diseases, including 
cancer. Indeed, an increasing interest to explore the anticancer 
effects of natural products in glioblastoma has emerged in last 
years (Park et al., 2017; Zhao et al., 2017; Vengoji et al., 2018). 
Hispanolone is a labdane diterpenoid that was first isolated from 
Ballota hispanica, a Labiatae species growing in Spain (Savona 
et al., 1978). Hispanolone derivatives have been reported to 
exhibit anti-inflammatory and anti-tumoral effects (Giron et al., 
2008; Traves et al., 2013; Mota et al., 2015). Thus, they have been 
shown to inhibit the growth and to induce apoptosis in various 
types of human cancers (Traves et al., 2013; Mota et al., 2015). 
Hispanolone derivatives, such as α-H, induce cell death of several 
tumor cells including melanoma, leukemia, hepatocellular 
carcinoma, and breast by activating caspase signaling and 
modifying the levels of pro-apoptotic and anti-apoptotic factors 
(Traves et al., 2013). Furthermore, these compounds also sensitize 
hepatocellular carcinoma cells to TRAIL-mediated apoptosis 
through upregulation of the death receptors DR4 and DR5 (Mota 
et al., 2015). Interestingly, hispanolone derivatives also inhibited 
tumor growth of melanoma and ovarian cells in vivo (Traves 
et al., 2013). Nevertheless, the anti-tumoral effects of α-H on 
glioblastoma cells remain unclear. Therefore, the aim of this study 
was to investigate the efficacy of α-H against glioma progression 
using in vitro and in vivo models. We showed that α-H increased 
apoptosis and reduced invasion and migration of glioma cells. In 
addition, we demonstrated that activities of MMP-2 and MMP-9 
were significantly inhibited by α-H treatment, whereas TIMP-1 
expression was increased. Further studies revealed that MMP 
expression might be regulated by the protein kinase p38MAPK. 
Finally, we also found that α-H inhibited in vivo tumor growth 
in mice subcutaneous xenograft, which was linked to impaired 
p38MAPK phosphorylation and reduced MMPs expression. 
Taken together, our data provide evidence that α-H may be a 
useful therapeutic agent for GBM treatment.
MATERIALS AND METHODS
Reagents
Western blot reagents were obtained from GE Healthcare 
(Pittsburgh, PA, USA). Fluorescent probes for caspase activity, 
caspase inhibitors, and annexin V assay kit were from BD 
Biosciences (San José, CA, USA). Culture media were from 
Lonza (Basel, Switzerland). MTT (3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyl tetrazolium bromide) and p38MAPK inhibitor 
(SB202190) were obtained from Sigma-Aldrich (St. Louis, MO, 
USA). Primary monoclonal rabbit antibodies against caspase 8 
(dilution, 1:1,000; #4927), cleaved-caspase 9 (dilution, 1:1,000; 
#7237), MMP-2 (dilution, 1:1,000; #4022), MMP-9 (dilution, 
1:1,000; #3852), p-p38 (dilution, 1:1,000; #9211), p38 (dilution, 
1:1,000; #9212), and TIMP-1 (dilution, 1:1,000; #8946) were 
purchased from Cell Signaling Technology, Inc. (Danvers, MA, 
USA). Caspase 3 (dilution, 1:1,000; sc-7148), Bid (dilution, 
1:1,000; sc-11423), Bcl-2 (dilution, 1:1,000; sc-783), Bcl-xL 
(dilution, 1:1,000; sc-634), and Bax (dilution, 1:1,000; sc-526) 
were purchased from Santa Cruz Biotechnology, Inc. (Dallas, 
TX, USA), and β-actin (dilution, 1:5,000; #A5441) was obtained 
from Sigma-Aldrich (St. Louis, MO, USA).
Anti-Ki67 (dilution 1:200) and Click-iT Tunel colorimetric 
IHC detection kit were from Thermo Fisher (Waltham, MA USA). 
DAB kit was provided from Vector laboratories (Burlingame, 
CA, USA).
Preparation of α-Hispanolol
α-hispanolol (α-H) was obtained from the natural diterpene 
hispanolone as previously reported (Giron et al., 2008) following 
the procedure described by Rodríguez-Hahn et al. (1995) 
(Supplementary Data 1 and Figure S1). The purity of α-H is 
higher than 99%. The corresponding 1H-NMR and 13C-NMR 
data are shown (Supplementary Figures S2, S3).
Stocks of α-H were prepared in DMSO and diluted in PBS 
before use (vehicle, maximum DMSO concentration 0.01%).
Cell Lines
Human glioma cell lines U87 and U373 and microglial BV2 
cell line were cultured in DMEM supplemented with fetal 
bovine serum (10% FBS) and 100 U/ml penicillin and 100 μg/
ml streptomycin. Cell lines were tested for mycoplasma using a 
Mycoplasma Detection Kit (Lonza) and stored in liquid nitrogen 
until use.
and invasion as well as by the induction of apoptosis in human glioblastoma cells. 
This research describes α-H as a new drug that may improve the therapeutic efficacy 
against glioblastoma tumors.
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MTT Assay for Cell Viability
Cells were incubated in triplicate in the presence of different 
concentrations of α-H for 24, 48, or 72 h. After treatment, 10 
μl of MTT solution (5 mg/ml) was added to each well, and the 
cells were then incubated at 37°C for 3 h. The insoluble product, 
formazan, was solubilized using DMSO, and the absorbance was 
read at 570 nm. Results are expressed as the percent reduction in 
cell viability compared with untreated control cultures for at least 
three independent experiments. The IC50 values were calculated 
by GraphPad Prism5.0 software.
Colony Formation Assays
U87 cells were seeded in six-well plates (5 × 102 cells/well) and 
allowed to adhere for 24 h before treatment. Then, cells were 
treated with α-H (10 μM) or vehicle as control for 48 h and 
were cultured for 14 additional days changing culture medium 
with α-H every 3 days. Then, cells were washed with PBS, fixed 
with 3% formaldehyde for 10 min, and permeabilized with 2% 
methanol for 2 min. Colonies were stained with 0.5% crystal 
violet in 20% methanol for 1.5 min, washed with running 
water to remove excess dye, and let wells air-dried. Relative 
clonogenicity of the diterpenoid-treated cells was computed as 
percentage of the number of colonies that formed compared 
with vehicle treated wells.
Cell Cycle Analysis
Cell cycle analysis was assessed by flow cytometry after staining 
with propidium iodide. After treatment of U87 cells with different 
concentrations of α-H, cells were washed twice in PBS and fixed 
in 70% ethanol. DNA was stained with 50 μg/ml propidium 
iodide (Sigma-Aldrich) and RNase A (1 mg/ml, Sigma-Aldrich) 
for 30 min at 37ºC in a dark environment, and fluorescence 
was measured using a MACSQuant (Miltenyi Biotics; Bergisch 
Gladbach, Germany).
Annexin-V Binding Assay for Apoptosis
α-H-induced cell apoptosis was assessed using an annexin V 
apoptosis detection kit according to manufacturer’s protocol (BD 
Pharmingen). Briefly, cells (2 × 105), both adherent and floating, 
were harvested after treatment with different concentration 
of α-H, washed twice with PBS, and resuspended in 100 μl of 
binding buffer. Annexin V-FITC was added to individual samples 
and incubated for 15 min under darkness. Then, 400 μl of 1X 
binding buffer was added to stop the reaction, and after adding 
propidium iodide, samples were analyzed by flow cytometry with 
MACSQuant (Miltenyi Biotec).
Cell Morphology
Cells were grown to 70% confluence and treated with different 
concentrations of α-H for 24 h. Changes in cell morphology 
were imaged using an inverted phase contrast microscope. 
Representative images from each case are shown.
Total Extracts and Western Blot Analysis
Cell lysates were prepared at 4°C using ice-cold buffer of total 
extract (0.5% Chaps, 10mM Tris pH 7.5, 1 mM Cl2Mg, 1 mM 
EGTA, 10% glycerol, 5 mM β-mercaptoethanol, and 1 μl/
ml of proteinase cocktail inhibitor), scraping off the plate 
and maintaining for 15 min under continuous shaking. After 
centrifugation, supernatants were collected, and solubilized 
proteins were quantified using a BCA protein assay kit (Pierce). 
Protein extracts were electrophoresed on SDS-PAGE (10–15% 
gels) and transferred onto polyvinylidenedifluoride membranes 
(GE Healthcare), which were incubated with the following 
antibodies: caspase 8, caspase 3, cleaved caspase 9, Bid, Bcl-2, 
Bcl-xL, Bax, MMP-2, MMP-9, TIMP-1, p-p38MAPK, p38MAPK, 
and β-actin. Membranes were incubated with HRP-conjugated 
secondary antibody. Enzymatic signal was detected using 
an enhanced chemiluminescence kit (Immobilon Westerns, 
Millipore, Merck, Darmstadt, Germany). β-actin was used as 
a loading control. Relative protein expression was analyzed by 
densitometry using Quantity One software (Bio-Rad, CA, USA). 
For all experiments, representative Western blots displaying 
results obtained from three independent experiments are shown.
Caspase Assays
The activity of caspase 3, 8, and 9 was determined in protein extracts 
using the fluorimetric substrates Ac-DEVD-AMC, Ac-IETD-AFC, 
and Ac-LEHD-AMC, respectively, according to the manufacturer’s 
instructions (BD Biosciences, San José, CA, USA).
Wound-Healing Assay
U87 cells were cultured in 24-well plates and grown to sub-
confluence. Then, cell monolayers were carefully scratched using 
a sterile pipette tip to create a linear “wound” in each well. Plates 
were washed twice with PBS to remove cell debris and incubated 
with indicated concentrations of α-H or vehicle as control. 
Wound healing process was monitored by photomicroscopy at 
different time points and quantified with Image J software.
Transwell Migration Assay
Cell invasion was determined using a transwell system (Boyden 
chamber, 8-μm pore size) from BD Biosciences (San Diego, 
CA, USA). Twenty thousand cells were placed on upper wells 
in serum-free medium in the presence or absence of amounts 
of α-H described in the figure. Migration-inducing medium 
containing 10% FBS was added to lower wells. After 48 h in a cell 
culture incubator, filters were washed twice with PBS, fixed, and 
crystal violet stained as described previously. Next, cells that did 
not migrate and were found on the upper side of the membrane 
were discarded by wiping with a cotton swab. Transmigrated cells 
to the lower side of the membrane were evaluated by: 1) light 
field microscopy through scanning randomly four fields per filter. 
2) Spectrophotometry after dissolving crystal violet with 0.1 M 
sodium citrate, 50% ethanol, pH 4.2, and measure absorbance at 
540 nm, which represent percentage of migrated cells.
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Gelatin Zymography
MMP-2 and MMP-9 activities were determined by gelatin 
zymography. Briefly, cells were treated with vehicle or different 
concentrations of α-H for 24 h. Supernatants were collected 
to prepare samples with loading buffer under nonreducing 
denaturing conditions and separated on an 8% SDS-PAGE 
gel containing 0.1% gelatin. After electrophoresis, gels were 
washed twice in 100 ml of 2% Triton X-100 to remove SDS and 
incubated in activation buffer (50 mM Tris–HCl, pH 7.8, 200 
mM NaCl, and 5 mM CaCl2) at 37°C overnight. Then, gel was 
stained with 0.5% Coomassie Brilliant Blue R250 for 1 h and 
destained with washing buffer (10% methanol and 5% glacial 
acetic acid) until clear bands suggestive of gelatin digestion 
were detected against the blue background. The gelatinolytic 
activities were quantified and analyzed by Quantity One 
software (Biorad, CA, USA).
Real-Time Quantitative RT-PCR
U87 cells were treated with vehicle or α-H for 24 h, and total 
RNA extraction was performed using the Trizol reagent 
(Life Technologies, Carlsbad, CA) following manufacturer’s 
recommendations. RNA concentration was quantified with an 
ultraviolet spectrophotometer (Nanodrop). cDNA was synthesized 
from 1 μg of total RNA using SuperScript™ III First-Strand 
Synthesis SuperMix (Life Technologies, Carlsbad, CA) according 
to the manufacturer’s instructions. Specific primers used for the 
PCR reaction are as follows: MMP-2, 5′-TGATGGTGTCTGCT 
GGAAAG-3’ (forward), 5′-CTACAGGACAGAGGGACTAG 
AG-3′ (reverse); MMP-9, 5′-CATTCAGGGAGACGCCCATT-3′ 
(forward), 5′-AACCGAGTTGGAACCACGAC-3′ (reverse); 
GAPDH, 5′- TCACTGCCACCCAGAAGA-3′ (forward), 5′-TAC 
CAGGAAATGAGCTTGAC-3′ (reverse), TIMP-1, 5´-AGAGT 
GTCTGCGGATACTTCC-3´ (forward), 5´-CCAACAGTGTA 
GGTCTTGGTG-3´ (reverse). Quantitative PCR (SYBR Green) 
analysis was performed on an ABI 7500 Fast sequence analyzer 
(Applied Biosystems, Darmstadt, Germany). Each sample was 
run in duplicate, and the relative mRNA levels of MMP-2 and 
MMP-9 were normalized to GAPDH as internal control. The 
experiment was performed for three times.
Generation of Tumor Xenografts
All animal care and experimental procedures were conducted 
in accordance with the guidelines for Animal Care and were 
approved by the Animal Committee of the Instituto de Salud 
Carlos III. Studies involving animals are reported in accordance 
with the ARRIVE guidelines for reporting experiments 
involving animals (Kilkenny et al., 2010; McGrath et al., 2010). 
For heterotopic/subcutaneous xenografts, 3 × 106 U87 cells 
resuspended in 100 µl of PBS were subcutaneously injected in 
the right flank of 5-week-old immunodeficient NSG (NOD scid 
gamma) mice. Once tumors reached approximately an average 
size of 200 mm3, the animals were randomly divided into the 
following experimental groups: those that were intravenous 
injected with 1 mg/kg body weight of α-H or those that received 
vehicle control on day 12, 15, and 18. Animals were monitored 
daily, and body weight was taken. Tumor sizes were measured 
once every 2 days using a calliper, and volume was calculated as 
tumor size = 1/2(length × width2). After 21 days, the mice were 
sacrificed, and the tumors were excised and stored at -80°C until 
further analysis.
Immunohistochemical Analysis of Tumors
Tumor tissues were harvested and embedded in paraffin, and 
5-μm cryostat sections were obtained. Expression of Ki67 
was detected after incubation with anti-Ki67 antibody (1:200; 
Thermo Fisher) and visualized using a colorimetric method 
(DAB kit; Vector Laboratories). Apoptotic cells were detected 
in tissues using Click-iT Tunel colorimetric IHC detection kit 
(Invitrogen). Five randomly selected anonymous tumor fields 
of each specimen were evaluated for positive cells by three 
independent investigators.
Statistical Analysis
All data are presented as mean ± standard deviation (S.D.) of 
at least three independent experiments. Data were analyzed 
using GraphPad Prism 5.0 (GraphPad Software, CA, USA). 
Statistical significance was estimated by Student’s t test for 
comparison between two groups. For comparison between two 
or more groups, one-way ANOVA, followed by Turkey’s multiple 
comparisons test was used. Tumor volumes of the treated groups 
were compared with those of the control group using a paired 
t test. Values at p < 0.05 were considered as statistically significant.
RESULTS
α-H Decreased Cell Viability and Colony 
Formation in Glioblastoma Cells
To explore the cytotoxic effects of α-H on glioblastoma cells, 
U87 and U373 lines were treated for 24, 48, and 72 h with 1, 10, 
25, 50, and 100 μM of α-H, and cell viability was determined 
by MTT assay (Figure 1A). The viability of cells treated with 
α-H decreased in a dose-dependent manner. In U87 cells, half 
maximal inhibitory concentration (IC50) of α-H was 29.1 µM 
after 24 h, which declined to 5.65 µM at 72 h. In comparison 
with U87 cells, U373 cells were less sensitive to α-H in all tested 
conditions, even showing an IC50 value higher than 50 μM at 
72 h. These results indicate that α-H exhibited more prominent 
effects on U87 cells, and we focused on these cells for further 
experiments. The cytotoxic effect of α-H was further confirmed 
using a clonogenic assay. As shown in Figure 1B, treatment with 
α-H also inhibited the colony forming ability of these cells.
Effects of α-H on Cell Cycle and Apoptosis 
in U87 Cells
To further explore the effect of α-H on cell proliferation and 
survival, flow cytometry measurements were performed to 
evaluate changes in cell cycle and apoptosis. Cells were treated 
with α-H (0, 1, 10, and 25 µM) and incubated for 24 h. Cell cycle 
analysis showed that α-H treatment significantly decrease the 
percentage of cells at G0/G1 phase followed by augmentation of 
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the sub-G1 population, suggesting that α-H induced apoptosis 
(Figure 2A). To confirm that apoptosis is involved in the cell 
growth inhibition induced by α-H, U87 cells were treated with 
different concentrations of α-H, and apoptosis was determined by 
annexin V and PI binding assay. Results showed that percentage 
of apoptotic cells (early and late apoptosis) increased from 6.84% 
on vehicle-treated samples to 28.71% and 89.01% when incubated 
with 10- and 25-µM α-H, respectively (Figure 2B). Additionally, 
phase contrast microscopy revealed morphological changes of 
U87 cells after α-H treatment characterized by smaller, rounded, 
FIGURE 1 | α-H inhibited proliferation and suppressed colony formation in glioblastoma cells. (A) U87 and U373 cells were treated with different concentrations 
of α-H (1–100 μM) for 24, 48, and 72 h. Cell viability was determined by MTT assay and reported as mean of the cell viability percentage ± S.D. from at least three 
independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 with respect to control. (B) Colony formation of U87 cells treated with α-H (10 μM) was evaluated 
by clonogenic assay. Representative images of crystal violet-stained cultures are shown on the left. Bar graph shows mean of the colony formation percentage ± 
S.D. from three independent experiments. **P < 0.01 with respect to vehicle-treated cells.
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FIGURE 2 | Effects of α-H on cell cycle and apoptosis in U87 cells. (A) U87 cells were treated with different concentrations of α-H (1, 10, and 25 μM) or vehicle as 
control for 24 h, then fixed in ethanol, and stained with propidium iodide. DNA content was determined by flow cytometry. Percentage of cells in each phase of the 
cell cycle (sub-G1, G0/G1, S, and G2/M) showed in the bar graph were calculated using Flowing software. (B) U87 cells were treated with different concentrations of 
α-H (1, 10, and 25 μM) or vehicle as control for 24 h. Collected cells were stained with annexin V-FITC and propidium iodide, and then analyzed by flow cytometry. 
Numbers in the plots represent percentage of the correspondent apoptotic population. Graph bars show percentage of correspondent cellular phenotype. 
(C) Microphotographs were taken after 24 h of incubation with different concentrations of α-H or vehicle as control. Characteristics of apoptosis such as cell 
rounding (due to loss of adhesion to substratum) and plasma membrane blebbing are observed in α-H-treated cells (arrows) (scale bars = 40 µm). Data presented 
are from one representative experiment out of three.
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and some floated cells and the presence of plasma membrane 
blebbing (Figure 2C). According to the differences in sensitivity 
previously reported, treatment of U373 cells with α-H for 24 h 
did not show any significant changes in morphology or apoptosis 
(Supplementary Figure S4).
Furthermore, in order to confirm the specific effects of α-H on 
glioblastoma cells, we examined its toxicity on the non-tumoral 
microglial cell line BV2. Treatment of these cells with α-H at 
the same range of concentrations (1, 10, 25, 50, and 100 μM) 
did not show any significant effect on viability (as low as 14.5% 
reduction at 100 μM), exhibiting similar results when apoptosis 
was analyzed (Supplementary Figure S5).
α-H Induced Glioblastoma Apoptosis 
via Caspase-Dependent Pathway and 
Regulation of Bax/Bcl-2 Ratio
Caspases are effector molecules of the apoptotic pathways 
classified by their mechanism of action as initiator (caspase 8 
and 9) or executioner caspases (caspase 3). First, we examined 
activation of caspase 3 on α-H-induced apoptosis in U87 
cells treated with different concentrations of the diterpenoid 
compound using the specific substrate Ac-DEVD-AMC. As 
shown in Figure 3A, caspase 3 activity was significantly induced 
by α-H in a dose-dependent manner. Co-incubation of cells with 
α-H (25 μM) in the presence of the pan caspase inhibitor Z-VAD-
FMK suppressed the increased caspase 3 activity (Figure 3A). 
Interestingly, α-H treatment also induced activation of caspase 
8 and 9 evaluated by using their specific substrates Ac-IETD-
AFC and Ac-LEHD-AMC (Figure 3A). Additionally, cell death 
induced by α-H was also significantly reversed in the presence of 
Z-VAD and specific inhibitors for caspase 8 (Z-IETD-FMK) and 
caspase 9 (Z-LEHD-FMK) (Figure 3B). We further confirmed 
the effects of α-H on caspase activation by detecting their cleaved 
forms on Western blot analysis (Figure 3C).
Bid, a pro-apoptotic Bcl-2 family member, is cleaved by caspase 
8, providing a link between death receptor and mitochondrial 
pathways of apoptosis (Billen et al., 2008). Furthermore, the 
prosurvival proteins Bcl-2 and Bcl-xL have been described to 
be upregulated in initial and recurrent glioblastoma patients, 
whereas downregulation of the pro-apoptotic protein Bax has 
been observed (Strik et al., 1999). In order to further explore 
potential signaling pathways by which α-H induced apoptosis, 
we evaluated the expression of the Bcl-2 family by Western 
blot (Figure 3D). Levels of Bcl-2 and Bcl-xL decreased after 
α-H treatment, whereas the pro-apoptotic Bax protein was 
upregulated, resulting in a significant increase in the ratio of Bax 
to Bcl-2 (Figure 3E). In addition, treatment with α-H diminished 
the inactive form of Bid.
α-H Inhibited Migration and Invasion of 
U87 Cells
One of the major causes of malignancy in GBM is the highly 
invasive ability of tumor cells (Tate and Aghi, 2009; Onishi et al., 
2011). Accordingly, we next evaluated the role of α-H on migration 
and invasion of U87 cells by wound healing scratch and transwell 
invasion methods, respectively. U87 cells treated with α-H displayed 
reduced mobility into the wound area. Treatment with α-H 
significantly reduced cell migration in a concentration-dependent 
manner; the inhibition rates were ~50.26%, 62.56%, and 63.74% 
with 1-, 10-, and 25-µM α-H, respectively (Figure 4A). These data 
were further supported by transwell migration assay. α-H decreased 
the percentages of invading cells to 62.56%, 41.29%, and 38.49% 
when cells were treated with 1, 10, and 25 µM of α-H, respectively 
(Figure 4B).
α-H Inhibited the Activity and Expression 
of MMP-2 and MMP-9 and Increased 
TIMP-1 Levels
Matrix metalloproteinases (MMPs) can degrade components of 
the extracellular matrix facilitating tissue remodeling and cell 
motility. MMP-2 and MMP-9 have been described to play an 
important role in the migration, invasion, and metastasis of 
glioma cells (Nakada et al., 2003). MMP activities are regulated 
by endogenous tissue inhibitors of metalloproteinases such as 
TIMP-1, being the MMP/TIMP imbalance important for the 
tumor cell survival (Bourboulia and Stetler-Stevenson, 2010; 
Jackson et al., 2016). Therefore, we first investigated whether α-H 
could regulate the expression and activity of MMP-2 and MMP-
9. Enzymatic functions were estimated by gelatin zymography 
assay. As shown in Figure 5A, the activities of MMP-2 and MMP-9 
were significantly reduced by α-H treatment. Additionally, 
α-H also downregulated the protein expression of MMP-2 and 
MMP-9 (Figure 5B) compared with the control condition. In 
agreement with the downregulation of MMP proteins, mRNA 
levels of MMP-2 and MMP-9 were also significantly decreased 
after α-H treatment (Figure  5C). By contrast, protein and 
mRNA expression levels of the inhibitor TIMP-1 increased 
after exposure of cells to α-H (Figures 6A, B). Analysis of the 
correlation between MMP-9 and TIMP-1 expression showed 
a significant decrease (Figure  6C), suggesting that a reduced 
MMP-9/TIMP-1 ratio might be associated with the inhibitory 
effects of α-H.
p38MAPK Signaling Is Involved in the 
Inhibition of MMPs by α-H
Mitogen-activated protein kinase (MAPK) signaling pathways 
have been reported to be involved in the regulation of MMPs 
(Chakraborti et al., 2003). Interestingly, p38MAPK activation 
has been described to mediate migration of human glioblastoma 
cells (Park et al., 2002; Gurgis et al., 2015; Sangpairoj et al., 
2017), and several natural products exhibited anti-tumoral 
effects via modulation of this pathway (Aroui et al., 2016; Yuan 
et al., 2019). Therefore, we evaluated whether α-H affected 
p38MAPK activation. We found that after treatment with α-H, 
the levels of p-p38 in U87 cells were significantly decreased 
in a dose-dependent manner (Figure  7A). Furthermore, 
when a specific inhibitor of p38MAPK (SB202190) was used, 
MMP-2 and MMP-9 protein levels were downregulated, 
whereas TIMP-1 was increased in a similar manner as after 
α-H treatment (Figure 7B). Additionally, a similar trend was 
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observed in mRNA expression of MMPs and TIMP-1 after 
p38 inhibition or α-H treatment (Figure 7C). These results 
indicated that α-H probably blocked the activation of MMPs 
via p38MAPK downregulation.
α-H Exhibited a Significant Inhibition of 
Tumor Growth and Impaired p38MAPK 
Signaling and MMP-9 Expression
In order to evaluate the preclinical effects of α-H, in vivo tumor 
growth was tested using a subcutaneous xenograft model. Tumor 
volumes were significantly decreased in α-H-treated mice 
compared with those in vehicle control (Figures 8A, B) with a 
reduction of 55.41% on day 21 (p = 0.0048) (Figure 8A). At the 
end of the treatment, the weight of isolated tumors showed a clear 
reduction on treated group (Figure 8C). No toxic effects and no 
significant change in body weight were observed (Figure 8D). 
Furthermore, consistent with the in vitro data, we confirmed that 
phosphorylation of p38MAPK was suppressed by α-H treatment 
in tumor tissues and reported the downregulation of MMP-9 
and a significant increase in TIMP-1 expression (Figure 8E). 
Moreover, immunohistochemical staining also revealed that α-H 
treatment inhibited Ki67 proliferation marker compared with 
control group and induced tumor apoptosis in vivo as indicated 
by the increase in TUNEL positive cells (Figure 8F).
Collectively, these in vivo results confirm that α-H treatment 
suppressed GBM tumor growth through similar mechanisms to 
those reported in the in vitro experiments.
FIGURE 3 | α-H induced apoptosis by regulating caspases and Bcl-2 family in human GBM cells. (A) U87 cells were treated for 24 h with different concentrations 
of α-H (1, 10, and 25 μM) or vehicle as control in the presence or absence of the indicated caspase inhibitors. Caspase 3, 8, and 9 activities were determined in cell 
extracts by fluorometry, using specific fluorigenic substrates as described in Materials and Methods. (B) U87 cells were treated for 24 h with 25-μM α-H or vehicle 
as control in the presence or absence of the caspase inhibitors indicated. Cell viability was determined by MTT assay. Results are reported as mean ± S.D. from 
three independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 with respect to the non-treated cells. aP < 0.05, bP < 0.01, and cP < 0.001 with respect to 
the α-H (25 μM) treated cells. (C-D) U87 cells were treated for 24 h with different concentrations of α-H (1, 10, and 25 μM) or vehicle as control, and caspases and 
members of Bcl-2 family protein levels were determined by Western blot. β-actin was used as loading control. A representative experiment of three performed is 
shown. Bars graphs show densitometry quantification of the bands from three independent experiments. (E) Bax/Bcl-2 ratio was calculated from data obtained by 
densitometry. *P < 0.05 and **P < 0.01 with respect to the non-treated cells.
FIGURE 4 | Effects of α-H on the motility and invasiveness of U87 cells. (A) Subconfluent U87 cultures were wound scratched and then incubated in media 
containing varying concentrations of α-H (1, 10, and 25 μM) or vehicle as control for 48 h. Cell migration was evaluated by photomicroscopy. Representative 
photographs showed the same area at time zero and after 48 h of incubation with or without α-H. Bars graph represents mean ± S.D. of percentage wound closure 
from three independent experiments. *P < 0.05 and **P < 0.01 with respect to the non-treated cells. (B) Cell invasion was determined using a transwell assay 
system. U87 cells treated with indicated concentrations of α-H (1, 10, and 25 μM) or vehicle as control were seeded into the upper chamber of the system in serum-
free media. The bottom well was filled with complete medium as chemotactic attractant environment. After 48 h, cells migrated to the bottom side of the filter were 
fixed, crystal violet stained, and evaluated by light microscopy (left panel). Magnification, ×100. Invasion rate is quantified by spectrophotometry after eluting cell 
staining, as described in Materials and Methods. Values represent the mean percentage of migrated cells ± S.D. from three independent experiments performed in 
triplicate. *P < 0.05 and **P < 0.01 with respect to the non-treated cells.
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FIGURE 5 | α-H inhibited the expression and activity of MMP-2 and MMP-9. U87 cells were treated with different concentrations of α-H (1, 10, and 25 μM) or 
vehicle as control for 24 h. (A) Conditioned medium was collected, and the activities of MMP-2 and MMP-9 were determined by gelatin zymography assay. A 
representative experiment is shown of three performed. Bars graphs show densitometry quantification of the bands and represent mean percentage of MMPs 
activities ± S.D. from three independent experiments. *P < 0.05 and **P < 0.01 with respect to the non-treated cells. (B) MMP-2 and MMP-9 protein levels were 
determined by Western blot. β-actin was used as loading control. A representative experiment is shown of three performed. Bars graphs show densitometry 
quantification of the bands and represent means MMPs/β-actin ratio ± S.D. from three independent experiments. *P < 0.05 and **P < 0.01 with respect to the 
non-treated cells. (C) mRNA expression of MMP-2 and MMP-9 was determined by quantitative PCR. Values represent the means ± S.D. of three independent 
experiments performed in triplicate. *P < 0.05 and **P < 0.01 with respect to the non-treated cells.
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DISCUSSION
Glioblastoma multiforme is the human rare disease most 
common of primary brain tumor, with a poor clinical outcome 
due to the uncontrolled proliferation and invasive abilities of 
the cells (Stupp et al., 2005; Stupp et al., 2009; Onishi et al., 
2011). Despite partial advances in therapeutic strategies, the 
ability of GBM to avoid immunosurveillance and its invasive 
properties have encouraged the search for the discovery of 
more effective agents.
Natural products have been currently used for the screening 
and design of new anticancer therapies, and several plant-
derived compounds have been reported to be potential anti-
glioma agents (Desai and Bhushan, 2017; Park et al., 2017). 
Hispanolone is a labdane diterpenoid isolated from Ballota 
hispanica, a plant species widely distributed in Spain (Savona 
et al., 1978). Several species of the genus Ballota are used in folk 
medicine with therapeutic purposes (Morteza-Semnani and 
Ghanbarimasir, 2019). Thus, effects as antiemetics, expectorants, 
diuretics, antispasmodics, antibacterials, sedatives, vermifuges, 
among others have been described for some of these species. 
Additionally, various labdane diterpenoids have been reported 
to possess important biological activities including anti-
inflammatory, antiviral, antibacterial, and antitumor properties 
(Traves et al., 2013; Endringer et al., 2014). Hispanolone 
derivatives have been shown to exhibit significant cytotoxic and 
anti-proliferative effects on tumorigenic cell lines (melanoma, 
leukemia, hepatocellular carcinoma, breast, ovarian, and 
several types of adenocarcinoma) (Giron et al., 2008; Traves 
et al., 2013; Mota et al., 2015). In the current study, we found 
that the hispanolone derivative α-H significantly inhibited cell 
growth and induced apoptosis in glioblastoma cells. Analysis of 
cell cycle distribution by flow cytometry revealed that α-H has 
no relevant effects on cell cycle arrest in U87 cells but caused a 
remarkable increase in the percentage of cells in sub-G1 phase 
(apoptotic population) in diterpenoid-treated cells in contrast 
to the control. Indeed, α-H treatment induced dose-dependent 
apoptosis as shown, by light field microscopy, typical features of 
apoptosis as cell shrinkage, chromatin condensation, blebbing, 
and the formation of apoptotic bodies. Furthermore, flow 
cytometry analysis using annexin V-FITC demonstrated that 
treatment with 25-µM α-H increased the percentage of apoptotic 
cells to 89.01%. Interestingly, α-H treatment did not affect the 
viability of non-tumoral microglial cells, suggesting selective 
action on glioblastoma cancer cells.
The ability to induce apoptosis constitutes an important 
property of an anticancer agent. Apoptosis can be activated by 
two main pathways, namely, the extrinsic death receptor and 
the intrinsic mitochondria pathways, where members of the 
caspase family of cysteine proteases as caspase 8 and caspase 9 
play crucial roles, respectively (Elmore, 2007; Logue and Martin, 
2008; Ouyang et al., 2012). Both pathways trigger the activation 
of caspase 3, a key executioner in the apoptotic machinery. 
Furthermore, both pathways are linked by Bid, a member of 
the Bcl-2 protein family, which is cleaved by caspase 8 and leads 
to activation of the mitochondrial pathway. The Bcl-2 family 
includes both anti-apoptotic (including Bcl-2 and Bcl-xL) 
and pro-apoptotic (including Bax) members, and it is well 
known for its key role in the control of apoptosis (Hengartner, 
2000). Resistance to apoptosis of tumor cells involves several 
mechanisms including overexpression of anti-apoptotic proteins 
(Bcl-2) or downregulation/mutation of pro-apoptotic proteins 
such as Bax. Indeed, the balance between expression levels of anti-
apoptotic Bcl-2 and pro-apoptotic Bax is critical for cell survival 
and death. In this study, we observed that α-H induced activation 
of caspase 3, caspase 8, and caspase 9. Moreover, a decrease in 
the protein levels of Bcl-2 and Bcl-xL was observed, while Bax 
protein levels were increased following treatment   with  α-H. 
FIGURE 6 | TIMP-1 expression is upregulated after α-H treatment. U87 cells were treated with different concentrations of α-H (1, 10, and 25 μM) or vehicle as 
control for 24 h. (A) TIMP-1 protein levels were determined by Western blot. β-actin was used as loading control. A representative experiment is shown of three 
performed. Bars graphs show densitometry quantification of the bands and represent means ± S.D. from three independent experiments. (B) mRNA expression of 
TIMP-1 was determined by quantitative PCR. Values represent the means ± S.D. of three independent experiments performed in triplicate. (C) MMP-9/TIMP-1 ratio 
was calculated from data obtained by densitometry. MMP-9 data were from Figure 5B. *P < 0.05 and **P < 0.01 with respect to the non-treated cells.
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As a consequence, the rise in the ratio of Bax to Bcl-2 was 
significantly enhanced, shifting the balance to the apoptotic 
status. Interestingly, protein levels of Bid-inactive form were 
decreased, suggesting that activated caspase 8 cleaved Bid after 
α-H treatment. Thus, these data provide evidences that the 
α-H induces apoptosis via both the extrinsic and the intrinsic 
pathways. Our results were consistent with previous studies from 
our group (Traves et al., 2013) in which hispanolone derivatives 
(including α-H) have been described to induce apoptosis through 
activation of death receptor and mitochondria pathway as well as 
modulation of expression levels of anti-apoptotic proteins (Bcl-2) 
and pro-apoptotic proteins (Bax) in several carcinoma lines.
Together with resistance to apoptosis, it is well known 
that angiogenesis and tumor motility are essential for the 
proliferation and survival of glioma cells (Tate and Aghi, 2009; 
Onishi et al., 2011). Extracellular matrix (ECM) is considered 
as an important barrier against glioma metastasis, and its 
degradation appears to be one of the key events in the complex 
process of glioblastoma invasion (Forsyth et al., 1999). Matrix 
metalloproteinases (MMPs) are proteolytic enzymes that play 
essential roles in the degradation of most components of the 
ECM such as collagen, laminin, fibronectin, and proteoglycans 
(Nathoo et al., 2005). In glioma tissues, MMP-2 and MMP-9 
are the two MMPs most highly expressed (Forsyth et al., 1999). 
Indeed, MMP-9 expression has been associated with the degree 
of malignant glioma, and it is considered as a good predictor 
of invasive glioma cell growth (Yan et al., 2011; Asuthkar 
et  al., 2012). Therefore, the search for new drugs that control 
the migratory and invasive capacities of glioblastoma cells is 
a critical issue. We investigated the activity of MMP-2 and 
FIGURE 7 | α-H treatment inhibited p38MAPK signal showing similar effects on MMPs and TIMP-1 expression as a specific p38MAPK inhibitor. (A) U87 cells were 
treated with different concentrations of α-H (1, 10, and 25 μM) or vehicle as control for 24 h. p-p38 and p38 protein levels were determined by Western blot. β-actin 
was used as loading control. A representative experiment is shown of three performed. Bars graphs show densitometry quantification of the bands and represent 
means ± S.D. from three independent experiments. (B) Cells were treated with a specific p38MAPK inhibitor (SB202190, 10 μM) or α-H (25 μM) for 24 h. MMP-9, 
MMP-2, and TIMP-1 protein levels were determined by Western blot. β-actin was used as loading control. A representative experiment is shown of three performed. 
Bars graphs show densitometry quantification of the bands and represent means ± S.D. from three independent experiments. (C) mRNA expression of MMP-9, 
MMP-2, and TIMP-1 was determined by quantitative PCR on U87 cells treated as in B. Values represent the means ± S.D. of three independent experiments 
performed in triplicate. *P < 0.05 and **P < 0.01 with respect to the non-treated cells.
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MMP-9 after α-H treatment and found that both MMPs were 
inhibited as confirmed by gelatin zymography. Further studies 
demonstrated that α-H also reduced the mRNA and protein 
expression levels of MMP-2 and MMP-9. In contrast, TIMP-1 
expression was upregulated in the presence of α-H. Linked to 
this, α-H exhibited inhibitory effects on invasion and migration 
of glioblastoma cells lines, as confirmed in in vitro transwell and 
scratch wound healing assays. In view of our data, it is reasonable 
to infer that the inhibitory effect of α-H on glioblastoma cell 
migration and invasion may be associated to MMP-2 and 
MMP-9 downregulation.
Although several labdane diterpenoids such as sclareol, 
coronarin D, andrographolide, and selected hispanolone derivatives 
have been described to exhibit potent antitumor activities via 
induction of apoptosis (Mahaira et al., 2011; Lim et al., 2012; 
Traves et al., 2013; Mishra et al., 2015; Mota et al., 2015; Wang et al., 
2015; Zhang et al., 2017), few data have been reported regarding 
their role on cell migration. Indeed, to the best of our knowledge, 
this is the first study describing the anti-invasiveness properties of 
hispanolone derivatives on glioblastoma tumors. Consistent with 
our results, the labdane diterpenoid andrographolide has been 
reported to inhibit the invasion and migration of several tumor 
cells including breast, colon, lung, and glioblastoma cancer cells 
through modulation of MMP expression (Shi et al., 2009; Chao 
et al., 2010; Lee et al., 2010; Chao et al., 2013; Yang et al., 2014; Zhai 
et al., 2015; Hsieh et al., 2017), whereas coronarin D suppressed 
TNF-induced cellular invasion via downregulation of MMP-9 
activity (Kunnumakkara et al., 2008). Interestingly, other natural 
products including neurostimulants as caffeine or flavonoids 
such as luteolin or naringin also exhibited inhibitory effects on 
migration of glioma cells via regulation MMP pathway (Cheng 
et al., 2016; Wang et al., 2017).
Several mechanisms, including MAPKs, JAK/STAT, PI3K/
AKT, and NF-κB, have been described to be involved in the 
modulation of MMP activation and cell migration. In this regard, 
accumulating evidence have suggested that p38MAPK activation 
plays a central role in the progression of tumorigenesis and 
regulation of MMPs and TIMPs in gliomas (Park et al., 2002; Yang 
et al., 2013). In this study, we found that α-H treatment led to a 
significant attenuation of p38MAPK phosphorylation. Therefore, 
through inactivation of p38MAPk signaling, α-H might decrease 
MMP levels resulting in inhibition of glioma migration. These 
results were further supported by the effects of specific p38MAPK 
inhibitor (SB202190). Thus, similar to α-H, SB202190 treatment 
suppressed the expression of MMPs and upregulated TIMP-1 
levels. Indeed, it is not unusual that natural products modulate 
MMP proteins via inactivation of p38MAPK. Compounds as 
resveratrol, berberine, curcumine, p-cymene, aloe-emodin, or 
baicalein have been reported to reduce MMP expression through 
prevention of p38MAPK activation in different cell lines, and 
others as caffeine and naringin have shown similar effects in 
glioma cells (Huang et al., 2008; Huang et al., 2011; Cao et al., 
2014; Zhang et al., 2014; Yan et al., 2015a; Yan et al., 2015b; Aroui 
et al., 2016; Li et al., 2016).
Finally, preclinical studies using an in vivo xenograft model of 
glioma showed that administration of α-H effectively inhibited 
tumor growth without significant off-target effects, establishing a 
proof of concept for the potential use of α-H as GBM treatment. 
Furthermore, consisting of the in vitro findings, inhibition of 
MMPs and p38MAPK were also observed in tumor tissues, as 
well as a reduction in the proliferation index and a significant 
increase of apoptotic cells.
In summary, our results demonstrate that α-H suppressed 
proliferation and elicited apoptosis in glioblastoma cells. The 
underlying mechanisms involved the induction of apoptosis 
through both extrinsic and intrinsic apoptotic pathways, via 
activation of caspase 3, 8, and 9, and an increased Bax/Bcl-2 
ratio. In addition, α-H also increased TIMP-1 expression and 
inhibited mRNA expression and protein levels of MMP-2 and 
MMP-9 and hence their enzymatic activities, which may be 
associated to the reduced migration and invasion capacities of 
glioblastoma cells exerted by α-H. Mechanistically, attenuation 
on MMP expression seems to be related with inactivation of 
p38MAPK pathway. Thus, this is the first report demonstrating 
that α-H inhibited glioblastoma progression in vitro and in vivo 
through implementation of tumor apoptosis and reduction of 
the metastatic potential of GBM cells. Taking into account these 
results together with that α-H seems to exhibit a low toxicity 
in non-tumoral cells and also in preclinical models, our study 
validate α-H as a promising anti-tumoral drug for GBM therapy.
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